Additional Metadata
Persistent URL dx.doi.org/10.1182/bloodadvances.2019000811, hdl.handle.net/1765/121565
Journal Blood Advances
Citation
Drygalski, A.V. (Annette Von), Giermasz, A. (Adam), Castaman, G, Key, N.S. (Nigel S.), Lattimore, S. (Susan), Leebeek, F.W.G, … Pipe, S.W. (Steven W.). (2019). Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Advances, 3(21), 3241–3247. doi:10.1182/bloodadvances.2019000811